Equities

Wakamoto Pharmaceutical Co Ltd

4512:TYO

Wakamoto Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)238.00
  • Today's Change0.00 / 0.00%
  • Shares traded114.50k
  • 1 Year change+20.20%
  • Beta0.9842
Data delayed at least 20 minutes, as of Nov 13 2024 05:33 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue7,7388,6608,383
OPERATING EXPENSES
Cost of revenue total4,1394,5524,027
Selling, general and admin. expenses, total3,2233,3273,717
Depreciation/amortization595958
Unusual expense(income)55315.46
Other operating expenses, total00.00--
Total operating expense7,9898,5508,402
Operating income(250)110(19)
Other, net(8.29)5646
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes159212285
Provision for income taxes507346
Net income after taxes109138239
Minority interest------
Net income before extra. Items109138239
Total extraordinary items------
Net income109138239
Inc.avail. to common excl. extra. Items109138239
Inc.avail. to common incl. extra. Items109138239
EPS RECONCILIATION
Basic/primary weighted average shares353535
Basic/primary eps excl. extra items3.143.986.87
Basic/primary eps incl. extra items3.143.986.87
Dilution adjustment------
Diluted weighted average shares353535
Diluted eps excl. extra items3.143.986.87
Diluted eps incl. extra items3.143.986.87
COMMON STOCK DIVIDENDS
DPS - common stock primary issue3.003.000
Gross dividend - common stock1041040
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.530.580.58
SUPPLEMENTAL INCOME
Depreciation, supplemental343375400
Total special items55315.46
NORMALISED INCOME
Normalized income before taxes214243290
Effect of special items on income taxes17110.89
Income tax excluding impact of special items678447
Normalized income after tax147159243
Normalized income avail. to common147159243
Basic normalized EPS4.224.577.00
Diluted normalized EPS4.224.577.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.